Access to End-of-Life Medicines in Care Homes: Barriers, Variability and Opportunities for Improvement

When a person reaches the final days of their life, the goal of care shifts from curing illness to ensuring comfort. In this delicate phase, known as end-of-life care, the body often experiences sudden and severe symptoms like pain, breathlessness, or agitation. To manage these distressing feelings, medical professionals rely on powerful medicines, some of which are strictly regulated by law because of their potential for misuse. These are called controlled drugs. In the United Kingdom, many people spend their last weeks in care homes, which are residential facilities that provide daily support and medical attention. For these residents, having immediate access to the right medicine at the right moment is not just a matter of convenience; it is a fundamental requirement for a dignified and peaceful passing. However, the journey of a medicine from a doctor's prescription to a patient's bedside is complex, involving multiple steps and different organizations. If any part of this chain breaks or slows down, the person suffering may endure unnecessary pain, and their family may face added anguish.

A team of researchers set out to understand exactly how this process works in practice within UK care homes. They wanted to know if staff members could get these essential medicines quickly when a resident's condition worsened, and what happens when they cannot. The team, led by researchers from the University of Cambridge and Marie Curie, conducted a large survey of care home workers across the country. They asked nearly 360 people, including managers, nurses, and support staff, about their recent experiences. The survey covered everything from how long it took to get a prescription to whether they had the right equipment and staff to give the medicine. The researchers also asked these professionals what they thought about a specific idea: keeping a small, secure supply of these powerful medicines on-site within the care home, ready to be used for any resident who needed them, rather than waiting for a new prescription for each individual.

The results revealed a significant gap between the need for these medicines and the ability to provide them. About one-third of the staff members surveyed reported that they had experienced delays in getting controlled drugs for end-of-life care in the three months before the survey. This was not a minor inconvenience; when access was delayed, the administration of the medicine was also delayed in nearly 90 percent of those cases. The impact was tangible and often severe. Staff who faced these delays were far more likely to report that the resident suffered, that the family was distressed, and that the care team felt helpless. The data showed that these problems were not evenly distributed. Staff in Wales reported delays more frequently than those in England, and larger care homes with more residents faced more hurdles than smaller ones. The reasons were varied and often interconnected. Sometimes a doctor was slow to write a prescription, or a pharmacy did not have the medicine in stock. At other times, the issue was internal to the care home, such as a lack of trained staff available to give the injection or difficulties in finding a second person to witness the process, which is a legal requirement for these specific drugs.

The researchers found that the current system, which relies on getting a specific prescription for each person before they get sick, works well when everything goes smoothly. However, it is fragile when a resident deteriorates rapidly. In these urgent moments, the time required to contact a doctor, wait for a prescription, and then wait for a pharmacy to fill it can stretch into hours. During this time, a person in severe pain may be left without relief. The survey highlighted that staff often felt they were fighting against a system that was too rigid to handle sudden changes. One manager described the current process as "hit and miss," noting that while it might work for planned care, it fails when a resident's condition changes unexpectedly. Another staff member recounted a situation where they had the right medication for one person but could not use it for another who was dying, simply because the law required the medicine to be prescribed specifically for the individual in need.

Despite these challenges, the care home professionals expressed a strong desire for a solution. When asked about the idea of keeping a central supply of these medicines on-site, the majority agreed it would be beneficial. This view was especially strong among those who had experienced delays. They believed that having a secure stock of medicines available immediately would allow them to act quickly when a resident's symptoms escalated, reducing the time spent waiting and the distress caused to the patient and their family. They also noted that this approach could reduce waste, as medicines currently prescribed for one person often go unused if that person's condition changes or if they pass away before the medicine is needed. However, the staff were not unaware of the risks. They were acutely aware that holding powerful drugs on-site requires strict rules. They raised concerns about security, the need for proper training, and the legal complexities of who is allowed to hold and manage these supplies. They emphasized that any such system would need clear guidelines, strong oversight, and support from external medical services to ensure safety and prevent misuse.

The study concludes that while many residents do receive timely care, the system is vulnerable to breakdowns that can cause unnecessary suffering. The delays are not caused by a single failure but by a series of small obstacles across the entire pathway of care, from the doctor's office to the care home shelf. The researchers suggest that keeping a central stock of medicines on-site could be a valuable addition to the current system, acting as a safety net when the standard process is too slow. However, they caution that this is not a simple fix. Implementing such a system would require careful planning, new laws or regulations, and a commitment to training staff and securing the medicines properly. The ultimate goal is to ensure that when a person is at the end of their life, the focus remains on their comfort and dignity, free from the frustration of bureaucratic delays. The findings suggest that with the right support and governance, care homes could be better equipped to handle the unpredictable nature of dying, ensuring that the final moments are met with compassion and effective care.